Therabody Expands Investment in Science with $10 Million Research Pledge, Scientific Partnerships and Official Scientific Advisory Board
LOS ANGELES, March 12, 2024 /PRNewswire/ -- Therabody, the leader in wellness technology, announced today the investment of more than $10M to fund initiatives that will continue to drive innovation and the scientific validation of their products. The company also announced the formalization of their Scientific Advisory Board and, significantly, a partnership with the American College of Sports Medicine (ACSM), the global research leader in the field of exercise, physical fitness and sports medicine.
- In an evolving regulatory landscape, Therabody believes that science is essential for leading the way forward as technology will transform healthcare over the next decade.
- Their $10 million investment in scientific research will drive an integrated strategy for scientific leadership in the industry with funds put toward scientific and clinical research studies across beauty, wellness and athletic performance over the next several years.
- Our Scientific Advisory Board, along with our significant investment in scientific research and partnerships, will ensure we remain at the forefront of our industry and dedicated to developing the most effective, scientifically validated products available today and in the future," said Monty Sharma, President and CEO of Therabody.
- Therabody has completed 21 scientific studies to date with 26 currently in progress.